Clinical trial
A Multicenter Study to Assess the Effect of Plasma Exchange in Accelerating the…
NCT00424788 · Biogen, Industry · Completed
Key facts
| NCT number | NCT00424788 |
|---|---|
| Title | A Multicenter Study to Assess the Effect of Plasma Exchange in Accelerating the Clearance of Natalizumab in Subjects With Multiple Sclerosis (MS) |
| Official title | A Multicenter Study to Assess the Effect of Plasma Exchange in Accelerating the Clearance of Natalizumab in Subjects With Multiple Sclerosis (MS) |
| Lead sponsor | Biogen, Industry |
| Status | Completed |
| Phase | Early Phase 1 |
| Study type | Interventional |
| Conditions | Relapsing Forms of Multiple Sclerosis |
| Intervention type | Drug, Procedure |
| Interventions | Plasma exchange, natalizumab treatment |
| Enrollment | 12 |
| Start date | Jan 1, 2007 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Jan 22, 2007 |
| Last update posted | Sep 4, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: